A new publication from Genes & Diseases; DOI 10.1016/j.gendis.2024.101441, discusses how Ce6-GFFY is a novel photosensitizer for colorectal cancer therapy.

Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite ...

Eunice S. Wang, MD, discusses the role of transplant eligibility in shaping treatment strategies for secondary acute myeloid leukemia.

Combining phototherapy with chemotherapy may provide a more powerful approach to combat aggressive tumors effectively.

Colorado physicians helped research a new treatment protocol for the most common form of childhood cancer that has “instantly ...

A new publication from Genes & Diseases; DOI  10.1016/j.gendis.2024.101441, discusses how Ce6-GFFY is a novel photosensitizer ...

As part of a high-resolution biosensing device without wires, the antennas could help researchers decode intricate electrical ...

Mutational signatures etched into the cells' genome by an anti-cancer drug called temozolomide (TMZ) uncover an Achilles' heel for TMZ chemotherapy resistance, according to new research.

A new breakthrough for spine and nervous system formation was successfully achieved by researchers where they were able to ...

(HealthDay News) — Genetic tests can show which patients with the blood cancer multiple myeloma should respond to targeted ...

HEALEY ALS, a platform trial testing multiple potential treatments for amyotrophic lateral sclerosis, is amending its master ...

FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...